These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9381307)

  • 1. [Clinical results with MGDF].
    Martín G
    Sangre (Barc); 1997 Apr; 42 Suppl 1():61. PubMed ID: 9381307
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.
    Fanucchi M; Glaspy J; Crawford J; Garst J; Figlin R; Sheridan W; Menchaca D; Tomita D; Ozer H; Harker L
    N Engl J Med; 1997 Feb; 336(6):404-9. PubMed ID: 9010146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy study.
    Geissler K; Yin JA; Ganser A; Sanz MA; Szer J; Raghavachar A; Hoelzer D; Martinez C; Taylor K; Kanz L; To LB; Archimbaud E
    Ann Hematol; 2003 Nov; 82(11):677-83. PubMed ID: 14530872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet growth factors: potential impact on transfusion medicine.
    Kuter DJ; Cebon J; Harker LA; Petz LD; McCullough J
    Transfusion; 1999 Mar; 39(3):321-32. PubMed ID: 10204598
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of thrombopoietin receptor agonists for clinical use.
    Ikeda Y; Miyakawa Y
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():239-44. PubMed ID: 19630808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
    Begley CG
    Thromb Haemost; 1997 Jul; 78(1):42-6. PubMed ID: 9198125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology evaluation: thrombopoietin, Genentech/Pharmacia & Upjohn.
    Goldberg J
    Curr Opin Mol Ther; 2000 Apr; 2(2):211-5. PubMed ID: 11249644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
    Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
    Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic potential of thrombopoietin].
    Geissler K
    Wien Klin Wochenschr; 2000 Oct; 112(19):829-34. PubMed ID: 11098533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
    Bennett CL; Evens AM; Andritsos LA; Balasubramanian L; Mai M; Fisher MJ; Kuzel TM; Angelotta C; McKoy JM; Vose JM; Bierman PJ; Kuter DJ; Trifilio SM; Devine SM; Tallman MS
    Br J Haematol; 2006 Dec; 135(5):642-50. PubMed ID: 17054431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and usefulness of autologous cryopreserved platelets.
    Wautier JL
    Lancet; 2002 Dec; 360(9349):1985. PubMed ID: 12493312
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokines for the treatment of thrombocytopenia.
    Ciurea SO; Hoffman R
    Semin Hematol; 2007 Jul; 44(3):166-82. PubMed ID: 17631181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietins and thrombopoiesis: a clinical perspective.
    Kuter DJ
    Vox Sang; 1998; 74 Suppl 2():75-85. PubMed ID: 9704427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin in the treatment of acute myeloid leukemia and in stem-cell transplantation.
    Linker C
    Semin Hematol; 2000 Apr; 37(2 Suppl 4):35-40. PubMed ID: 10831287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human thrombopoietin: clinical experience and in vivo biology.
    Vadhan-Raj S
    Semin Hematol; 1998 Jul; 35(3):261-8. PubMed ID: 9685172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokine in cancer chemotherapy--clinical trials of IL-3, IL-11 and thrombopoietin against thrombocytopenia].
    Kudoh S; Yamada M
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):171-6. PubMed ID: 9474925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-rHuMGDF ameliorates thrombocytopenia in carboplatin-treated rats without inducing myelofibrosis.
    Ide Y; Harada K; Imai A; Yanagida M
    Int J Hematol; 1999 Aug; 70(2):91-6. PubMed ID: 10497847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the safety and biologic effects of PEG-rHuMGDF in clinical trials.
    Sheridan W; Menchaca D
    Stem Cells; 1998; 16 Suppl 2():193-8. PubMed ID: 11012191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
    Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
    Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.